Effects of ciprofol on respiratory-related adverse incidence in patients with obesity during painless gastroscopy: a prospective, randomized clinical trial
Abstract Background Ciprofol is an intravenous anesthetic agent which in low doses produces sedation. It was developed via structural modification of propofol. Ciprofol is claimed to reduce respiratory depression. The object of the present study was to investigate whether or not ciprofol did actuall...
Saved in:
| Main Authors: | Yanjing Zhang, Danru Xie, Feifei Li, Mengjiao Che, Yaoheng Yang, Geng Li, Yiwen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Perioperative Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13741-025-00529-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of ciprofol for gastroscopy in patients with obesity: a randomised clinical controlled trial using different weight-based dosing scales
by: Danru Xie, et al.
Published: (2025-03-01) -
The novel ciprofol versus propofol during gastroenteroscopy in Chinese patients: a meta-analysis
by: Xiaoyan Liang, et al.
Published: (2025-06-01) -
The median effective dose of ciprofol combined with a low-dose sufentanil for gastroscopy in obese or nonobese patients: a dose-finding study using Dixon’s up-and-down method
by: Jie Zhao, et al.
Published: (2025-02-01) -
Safety and efficacy of ciprofol versus propofol for gastrointestinal endoscopy: a meta-analysis
by: Xi Cheng, et al.
Published: (2025-03-01) -
The Median Effective Dose of Ciprofol Combined with Sufentanil for Inhibiting Responses to Gastroscope Insertion in Obese Patients: A Prospective, Single-Center Study
by: Xue Z, et al.
Published: (2025-05-01)